Shinya Yuki, CEO of Elix will participate in the following panel discussion and focused session at the “CBI Society Annual Meeting 2021: Digital Transformation Revolutionizes Life Science ~New Strategies of AI-Driven Drug Discovery~” which will be held from October 26th to 28th, 2021.

– Overview of the Panel discussion
Title : “The Pharmaceutical Industry from the Perspective of AI Startups”
Date and time: Tuesday, October 26th, 13:00 JST – 14:30 JST

Chair: Taiei Yamada (NVIDIA)
I-01 Daitaro Misawa (SyntheticGestalt)
“How to overcome the barriers to AI drug discovery”
I-02 Shinya Yuki (Elix, Inc.)
“AI Drug Discovery at Elix”
I-03 Koji Hazama (ExaWizards Inc.)
“Shaping a new way of drug discovery through the internalization of digital technology”

– Overview of the Corporate Session
Title : “Chemical Data Science and Artificial Intelligence Discussion” organized by the Computational Toxicology Study Group
Date & Time : Thursday, October 28th from 13:00-14:30 (JST)

Moderators:
Kohtaro Yuta (In Silico Data, Ltd.)
Yoshihiro Uesawa (Meiji Pharmaceutical University)
Hiromasa Kaneko (School of Science and Technology, Meiji University)

Lecturers:
Hiromasa Kaneko (School of Science and Technology, Meiji University)
“Molecular Design and Material Design Using Artificial Intelligence”
Shinya Yuki (Elix, Inc.)
“Introduction of AI Drug Discovery and Case Studies at Elix”
Kazumasa Furuta (Fujitsu Limited)
“Fujitsu’s research style in the new normal era”
Hiroshi Ouchiyama (Intel Corporation)
“Intel’s Approach to AI”

– Chem-Bio Informatics Society(CBI) Annual Meeting 2021 official page
https://cbi-society.org/taikai/taikai21/index_e.html